8-K: CTS Corp. Targets 10% Growth, Diversifies Markets

CTS Corporation outlines a strategy for 10% organic and inorganic growth, driven by diversification into industrial, medical, and aerospace & defense markets, alongside new product innovations.

Summary

• CTS Corporation aims for a 10% annual revenue CAGR, combining mid-single-digit organic growth with strategic M&A.
• The company reported Last Twelve Months (LTM) revenue of $541 million and LTM Adjusted Diluted EPS of $2.23 as of December 2025.
• Diversified end markets (industrial, aerospace & defense, medical) now account for 57% of revenue, up from 35%, and are experiencing strong growth.
• Industrial market LTM revenue grew 12% year-over-year to $140 million, Medical market LTM revenue grew 21% to $85 million, and Aerospace & Defense LTM revenue grew 20% to $83 million.
• The transportation market saw a 7% year-over-year decline in LTM revenue to $234 million, but new powertrain-agnostic products like eBrakeTM are expected to drive future growth.
• FY 2026 guidance projects revenue between $550 million and $580 million and Adjusted Diluted EPS between $2.30 and $2.45.
• The company plans to allocate 60-80% of free cash flow to strategic M&A and return 20-40% to shareholders, having returned $300 million since 2013.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive outlook, driven by strong growth in diversified markets and a clear strategy for organic and inorganic expansion, despite some headwinds in the transportation sector.

Positives

• Strong growth in diversified end markets: Industrial (+12% YOY LTM revenue), Medical (+21% YOY LTM revenue), and Aerospace & Defense (+20% YOY LTM revenue).
• Diversified markets now represent 57% of total revenue, reducing reliance on the transportation sector.
• Robust new product pipeline, including piezo formulations, medical applications, and eBrakeTM, poised to drive future organic growth.
• Clear strategy for 10% organic and inorganic growth, supported by a strong balance sheet and cash flow for M&A.
• Consistent return of capital to shareholders, with $300 million returned since 2013 through Q4 2025.
• LTM Adjusted EBITDA Margin of 23% and LTM Adjusted Diluted EPS of $2.23 demonstrate solid profitability.
• High operating cash flow, with LTM operating cash flow at 156% of net earnings and LTM free cash flow at 130% of adjusted net earnings.

Negatives

• Transportation market LTM revenue declined 7% year-over-year to $234 million.
• FY 2026 outlook anticipates softness in commercial vehicle-related sales.
• Light vehicle production in 2026 is expected to be flat to slightly down year-over-year.
• Adjusted SG&A Expense % LTM was 17.8%, which is slightly above the long-term target range of 15-17%.

Risks

• Supply chain disruptions, including the availability and cost of rare earth elements, minerals, and metals.
• Changes in the economy, including inflationary and/or recessionary conditions and increased tariffs.
• Unanticipated issues in integrating acquisitions.
• Funding of contracts by the U.S. Government.
• Rapid technological change.
• General market conditions in the transportation, industrial, aerospace and defense, and medical markets.
• Reliance on key customers.
• Unanticipated public health crises, natural disasters, or other events.
• Environmental compliance and remediation expenses.
• Ability to protect intellectual property.
• Pricing pressures and demand for products.
• Risks associated with international operations, including trade and tariff barriers, exchange rates, and political and geopolitical risks (e.g., impact of tariffs on China, Canada, Mexico, U.S./China relations, geopolitical conflicts).
• Write-offs of goodwill on the balance sheet.
• The amount and timing of any share repurchases.
• The effect of any cybersecurity incidents on the business.

Future Outlook

CTS Corporation projects FY 2026 revenue between $550 million and $580 million and Adjusted Diluted EPS between $2.30 and $2.45. The company anticipates continued growth in diversified end-markets, while expecting softness in commercial vehicle sales and flat to slightly down light vehicle production. Long-term targets include a +10% annual revenue CAGR, 36-40% Adjusted Gross Margin, 15-17% Adjusted SG&A Expense, and 4-6% R&D Expense.

Management Comments

• "CTS is a Leading Designer and Manufacturer of Custom Engineered Solutions that Sense, Connect and Move Enabling an Intelligent and Seamless World."
• "CTS is positioned to deliver 10% organic and inorganic growth."
• "Evolution 2030 establishes our long-term goals and drives our execution, placing a strong emphasis on growth, operational excellence, and engagement."

Industry Context

StockSavvy.ai notes that CTS Corporation's strategic focus on diversified end markets like industrial, medical, and aerospace & defense aligns well with broader industry megatrends such as automation, healthcare innovation, and electrification. While the transportation sector faces headwinds from flat light vehicle production and commercial vehicle softness, the company's development of powertrain-agnostic products like eBrakeTM positions it to capture future opportunities within the evolving automotive landscape. The strong growth in its diversified segments demonstrates effective execution against these secular themes, potentially offsetting cyclical pressures in traditional markets.

Comparison to Industry Standards

• CTS's LTM Adjusted EBITDA Margin of 23% and LTM Adjusted Diluted EPS of $2.23 indicate solid profitability, which can be benchmarked against peers like Sensata Technologies (ST), TE Connectivity (TEL), or Amphenol (APH) in the sensor and connectivity solutions space.
• The 10% diversified end market revenue CAGR (2019-2025) suggests strong performance in high-growth areas, potentially outperforming the mid-single-digit estimated market growth for these segments.
• The company's target of mid-single-digit organic growth and ~5% growth from M&A for a total 10% CAGR is ambitious and would place it among the faster-growing industrial technology companies.
• The decline in transportation revenue (-7% YOY LTM) is a point of concern, reflecting broader industry trends in certain automotive segments, but the focus on powertrain-agnostic solutions like eBrakeTM aims to mitigate this by increasing content per vehicle, similar to how other automotive suppliers adapt to EV transitions.

Stakeholder Impact

• Shareholders: Potential for increased value through targeted 10% annual growth, strategic M&A, and continued capital returns (dividends & repurchases).
• Employees: Emphasis on engaging and developing talent, and establishing a culture of continuous improvement through "Evolution 2030" initiatives.
• Customers: Focus on deep custom engineered capability, technical expertise, and regional capabilities to serve customers, reducing cross-border challenges.
• Suppliers: Potential for supply chain disruptions (e.g., rare earth elements) could impact relationships and costs.
• Creditors: Maintenance of a healthy balance sheet with leverage targets of 1.0-2.5x.

Next Steps

• Continued execution of the "Evolution 2030" strategy focusing on growth, operational excellence, and talent engagement.
• Further investment in business development resources, process, and technology capabilities.
• Disciplined capital investments to support the diversification strategy.
• Pursuit of strategic M&A opportunities that strengthen customer relationships, enhance technology, expand end markets, and offer attractive financials.
• Development and commercialization of new products like eBrakeTM and Drive-PadTM.

Key Dates

Recommendation

The filing presents a compelling growth strategy with strong performance in high-growth diversified markets, offsetting weaknesses in the transportation sector. The company's clear financial targets for 2026, coupled with a disciplined capital allocation framework prioritizing M&A and shareholder returns, suggest a positive trajectory. The focus on megatrends and a robust new product pipeline indicates sustainable long-term value creation, making it an attractive investment for growth-oriented portfolios.

Keywords

CTS Corporation, Investor Presentation, SEC Filing, Financial Performance, Growth Strategy, Diversified Markets, Industrial, Medical, Aerospace & Defense, Transportation, Electrification, Automation, Healthcare Innovation, eBrake, M&A, Adjusted EPS, EBITDA, Revenue Guidance, Supply Chain, Risk Management